COAG · Hemab Therapeutics Holdings, Inc.
$54.94
+0.99 (+1.84%)
At close · Aug 14
Market Cap
$2.57B
Shares
46.71M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-21 | 2026-03-31 | |
| 8-K | 2026-05-21 | — | |
| 8-K | 2026-05-11 | 2026-05-08 | |
| 8-K | 2026-05-04 | — |
Showing 1–7 of 7 filings
Key facts
CIK
2114044
CUSIP
423494103
13F (30d)
61 filings
57 filers
Visit website
Investor relations